alessandra bergadano

Dr. alessandra bergadano

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Veterinary Anaesthesia and Analgesia
Verified
Journal Article
Closed access
PDF file
DCDaniela Casoni
Daniela Casoni
EAEva M Amen
Eva M Amen
MBMathieu Brecheisen
Mathieu Brecheisen
BKBasil Kuennecke
Basil Kuennecke
TMThomas Müggler
Thomas Müggler
ABalessandra bergadano
alessandra bergadano

27 March 2024 in Animals
Verified
Journal Article
Open access
PDF file
GPGwenda Pargätzi
Gwenda Pargätzi
ABalessandra bergadano
alessandra bergadano
CSClaudia Spadavecchia
Claudia Spadavecchia
RTRegula Theurillat
Regula Theurillat
WTWolfgang Thormann
Wolfgang Thormann
OLOlivier Levionnois
Olivier Levionnois
The present study aimed to examine the stereoselective pharmacokinetics of racemic ketamine in dogs at low doses. The secondary aims were to identify associated behavioural effects and propose a ketamine infusion rate. The study was conducted on nine intact male beagles, with each dog undergoing two treatments (BOL and INF). For treatment BOL, an intravenous bolus of 1 mg/kg was administered over 2 min. The treatment INF involved an initial bolus of 0.5 mg/kg given over 1 min, followed by an infusion at 0.01 mg/kg/min for 1 h. Blood samples were collected for pharmacokinetic analysis. The median R/S enantiomer ratio of ketamine remained close to 1 throughout the study. Levels of S-norketamine were significantly higher than those of R-norketamine across all time points. Based on the collected data, the infusion rate predicted to achieve a steady-state racemic ketamine plasma concentration of 150 ng/mL was 0.028 mg/kg/min. Higher scores for behavioural effects were observed within the first five minutes following bolus administration. The most common behaviours observed were disorientation, head movements and staring eyes. Furthermore, employing ROC curve analysis, a racemic ketamine plasma concentration of 102 ng/mL was defined as the cut-off value, correlating with the occurrence of undesirable behavioural patterns.

11 January 2019 in Journal of Biological Methods
Verified
Journal Article
Open access
PDF file
ABalessandra bergadano
alessandra bergadano
EAEva Maria Amen
Eva Maria Amen
BJBjörn Jacobsen
Björn Jacobsen
SBSara Belli
Sara Belli
AVAnthony Vandjour
Anthony Vandjour
CSClaudia Senn
Claudia Senn
Drug concentrations in cerebrospinal fluid (CSF) are typically used as a as a surrogate measure of their availability in the CNS, and CSF penetration in animal studies are used for assessment of CNS drug delivery in early preclinical drug development. The minipig is a valid alternative to dogs and non-human primates as non-rodent species in preclinical research, but this species presents anatomical peculiarities that make the serial collection of CSF technically challenging. A minimally-invasive serial cerebrospinal fluid collection model via catheterization of the subarachnoid space in conscious minipigs was developed allowing assessment of longitudinal drug pharmacokinetics in the central nervous system in preclinical research. Shortly, the subarachnoid space was accessed in the anesthetized minipig by puncture with a Tuohy needle; when CSF was flowing through the needle a catheter was advanced and thereafter tunneled and fixed on the back. The PK of peptide A administered subcutaneously was performed and CSF could be sampled in the conscious animals for up to 48 h. When compared to the plasma kinetic data, there was a clear difference in the elimination phase of Pept. A from CSF, with an apparent longer average terminal half-life in CSF. The 3Rs are addressed by reducing the number of animals needed for a pharmacokinetic profile in central nervous system and by improving the validity of the model avoiding biases due to anesthesia, blood contamination, and inter-individual variability.

18 September 2025 in Lab Animal
Verified
Journal Article
Open access
PDF file
TVTommaso Virgilio
Tommaso Virgilio
ILIrene Latino
Irene Latino
CPChiara Pizzichetti
Chiara Pizzichetti
KCKamil Chahine
Kamil Chahine
ACArianna Capucetti
Arianna Capucetti
SFSantiago F.GOnzalez
Santiago F.GOnzalez
Anesthesia is indispensable for minimizing stress during invasive procedures. However, anesthesia can induce undesired effects on the organism and its physiological homeostasis. In experiments involving animals, these consequences may reduce animal welfare and alter experimental outcomes. Moreover, most of the studies characterizing the effects of murine anesthetic protocols on animal welfare do not explore the impact of prolonged anesthesia for procedures lasting more than 2 h. Here we investigated the effect of prolonged anesthesia on vital parameters and immune responses to vaccination, comparing isoflurane (Iso), ketamine–xylazine (KX), and KX with oxygen supplementation (KXO2), in the presence or absence of buprenorphine (BPP). KX induced hypoxia and 100% mortality, which were prevented by oxygen supplementation (KXO2) and were not associated with BPP. By contrast, Iso induced safe and fast induction and recovery. Furthermore, we investigated the effects of these protocols on the immune responses and motility of immune cells following vaccination. The results showed that KX reduced immune cell numbers and increased cell death, complemented by elevated levels of the inflammatory proteins IL-6 and IFNγ. In addition, KX altered the motility patterns of T cells, B cells and neutrophils, potentially influenced by hypoxia. Conversely, Iso exhibited fewer immune artifacts, regardless of BPP. These findings highlight the importance of evaluating anesthesia protocols with respect to animal welfare and experimental reproducibility, especially for immunological studies. Oxygen supplementation emerged as an important refinement to mitigate hypoxia in KX. Iso showed superior safety and fewer artifacts compared with KX and KXO2, demonstrating its suitability for immunological research and intravital microscopy.

2 November 2021 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
KOKatharina A. C. Oswald
Katharina A. C. Oswald
SBSebastian F. Bigdon
Sebastian F. Bigdon
ACAndreas Croft
Andreas Croft
PLPaola Bermudez Lekerika
Paola Bermudez Lekerika
ABalessandra bergadano
alessandra bergadano
CAChristoph Emanuel Albers
Christoph Emanuel Albers
The rat model is a common model for intervertebral disc (IVD) and spinal research. However, complications remain challenging. Standard Operating Procedures (SOPs) are validated methods to minimize complications and improve safety and quality of studies. However, a SOP for rat spinal fusion surgery has been missing until now. Therefore, the aim of the study was to develop a SOP for spinal tail disc surgery in elderly Wistar rats (419.04 ± 54.84 g). An initial preoperative, intraoperative, and postoperative surgical setup, including specific anaesthesia and pain management protocols, was developed. Anaesthesia was induced by subcutaneous injection of a pre-mixture of fentanyl, midazolam, and medetomidin with the addition of 0.5% isoflurane in oxygen and caudal epidural analgesia. The surgery itself consisted of the fixation of a customized external ring fixator with ⌀ 0.8 mm Kirschner wires at the proximal rat tail and a discectomy and replacement with bone morphogenetic protein coated beta-tricalcium-phosphate carrier. The postoperative setup included heating, analgesia with buprenorphine, and meloxicam, as well as special supplementary food. Anaesthesia, surgery, and pain management were sufficient. In the presented optimized SOP, no animals developed any complications. A SOP for spinal surgery in elderly rats in an in vivo spinal fusion model was developed successfully. This novel protocol can improve transparency, reproducibility, and external validity in experimental rat spinal surgery experiments.

12 December 2024 in Laboratory Animals
Verified
Journal Article
Closed access
MFMathilde Flueck-Giraud
Mathilde Flueck-Giraud
HSHeike Schmidt-Posthaus
Heike Schmidt-Posthaus
ABalessandra bergadano
alessandra bergadano
IAIrene Adrian-Kalchhauser
Irene Adrian-Kalchhauser
Fish are increasingly used as experimental animals across research fields. Currently, around a quarter of all experimental animals used are fish. Less than 20% of these are standard model species. Welfare assessments for experimental fish are in their infancy compared with those for rodents. This can be attributed to the diversity of species used, the relative recency of fish as the go-to model for research, and challenges to assess welfare in non-vocal underwater species. The lack of guidelines and tools presents a challenge for researchers (particularly, for newcomers), for ethics committees and for implementing refinement measures. Here, we present an adaptable, user-friendly score sheet for fish based on MS Excel. The parameters are based on a literature review, have been validated by expert interviews and evaluated by a fish pathologist. The tool allows scoring of individual fish as well as groups, calculates summary scores and visualizes trends. We provide the underlying literature, give use examples and provide instructions on the adaptation and use of the score sheet. We hope that this tool will empower researchers to include welfare assessment in their routines, foster discussions on fish welfare parameters among scientists, facilitate interactions with ethics committees and, most importantly, enable the refinement of fish experiments.